Connect with us
[ad_1] Getty Images; Chelsea Jia Feng/BI Dividend stocks are set to surge as investors deploy $6 trillion from money-market funds, Bank of America says. Investors could...
[ad_1] Pharmaceutical sector mainstay Gilead Sciences (NASDAQ: GILD) has had many good days on the stock exchange, but Monday wasn’t one of them. On the back...
[ad_1] Nations Financial Group Inc. IA ADV lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 60.2% during the 4th quarter,...
[ad_1] This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/stock-market-movers-apple-amazon-google-ford-51675354870 Updated...
[ad_1] Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t...